Global Cancer Diagnostics Market- Size, Outlook, Trends and Forecast (2024 – 2032)

Published : 30 Aug 2024

Report Type : Global

Share This On

Download Free Sample Now Buy This Report

Home > Reports > Diagnostics > Healthcare > Global Cancer Diagnostics Market- Size, Outlook, Trends and Forecast (2024 – 2032)

Description Table of Contents Scope of the Report

Global Cancer Diagnostics Market- Size, Outlook, Trends and Forecast (2024 - Size

Study Period

2018 - 2030

Base Year For Estimation

2023

Forecast Data Period

2024-2030

Historical Data Period

2018-2021

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Cancer diagnostic market now is the one which is facing many challenges. The main factors are an early diagnosis of the disease and high diagnostic features. These are the prior things to be considered as primary analysis. This cancer diagnostic market is segmented priory into three categories based on technology, application, and region. Technology-based is categorised into Platform based and Instrument based. Some of the major players in the market are GE Healthcare, Thermo Fisher Scientific, Abbott, Qiagen, and C.R.Bard. Cancer diagnostic market growth rate is expected to be $13.3 billion by 2020 from $7.4 billion in 2015, so it is estimated that by 2023 it can be $16.4 billion at a CAGR of 13.9%.

Cancer diagnostic market share:

Technology, application, and region mainly classify cancer diagnostic market. And the technology is categorised into a platform based and instrument based. This instrument based is having the most significant share in the market and the same is expected in the forecast period (2018-2024).

Cancer diagnostic market size:

North America is the dominant one due to its advanced and developed healthcare infrastructure and government initiatives. During

Global Cancer Diagnostics Market- Size, Outlook, Trends and Forecast (2024 - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

the forecast period, Asia-Pacific is going to lead the market with highest CAGR.

Cancer diagnostic market growth:

As of today, the population is rapidly increasing, and the cancer growth rate is high due to consumption of cancer-causing products. The cancer diagnostic service centres are facing the challenges to have better solutions for diagnosing cancer. Increasing incidence of cancer and tumours are driving the market.

Cancer diagnostic market industry analysis:

The cancer diagnostics market is mainly segmented based on type and application. By nature, it is segmented into a platform found an instrument based. Based on the use it is segmented into lung cancer, breast cancer, colorectal cancer, and melanoma.

Cancer Diagnostic Market Outlook:

Cancer is treated as the most prominent threat in today’s world, so all the industries are trying to improve the diagnostic methodology to reduce the cancer threats. And provide a miniaturised way of treating the patients. The leading company profiles are GE Healthcare, Abbott, Agilent technologies are the ones.

Cancer Diagnostic Market Trends:

We categorize this cancer into secular trend market as this cancer is the one which is increasing day by day and

You can also purchase parts of this report. Do you want to check out a section wise price list

Global Cancer Diagnostics Market- Size, Outlook, Trends and Forecast (2024 - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

year by year. If we compare the diagnostic growth rate, it can be estimated to be $16.1 billion by 2023. GE healthcare partner with healthcare leaders to leverage a global policy change and implement a successful healthcare system. Abbott Laboratories CEO and chairman announced a deal on February 1, 2016, which is going to create a premier point-of-care and analyse infectious diseases.

Cancer Diagnostic Market Research Reports Include:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
Identify the latest developments, market shares and strategies that are employed by the major market players, such as
GE Healthcare
Abbott
Agilent Technologies

Exclusive Benefits

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.